admin

Partnership to supply the global marketplace with pharmaceutical API phytocannabinoid ingredients formulated with a clinically proven drug delivery system technology. The partnership will allow Geocann to have the exclusive distribution rights of Averix Bio phytocannabinoid ingredients in the rapidly evolving South American marketplace where they will offer pharmaceutical API starting materials, available as either stand-alone […]

ALTEROLA BIOTECH SELECTS AVERIX BIO TO SUPPLY API PHYTOCANNABINOID CBD ISOLATE BIRKENHEAD, UK (Dec. 24, 2021) — Alterola Biotech Inc. (OTC PINK:ABTI) today announces the execution of a Memorandum of Understanding (MoU) to enter into a Good Manufacturing Practice (GMP) supply agreement with Averix Bio LLC (“Averix Bio”), a North Carolina-registered company whose registered office is

Averix Bio, a Botanical-based Cannabinoid Supplier, Achieves cGMP 21 CFR Part 210 and Part 211 and ICH Q7 Compliance Pharmaceutical, nutraceutical and cosmetic companies can now secure API Phytocannabinoid CBD isolate for preclinical, clinical and manufacturing   Wilson, N.C., (Oct. 12, 2021) — Averix Bio is proud to announce that it has successfully completed an independent audit